{"entity":{"type":"insider","cik":"0001255348","url":"/insider/0001255348","json_url":"/insider/0001255348.json","name":"CATLIN AVERY W","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":18,"n_filings":15,"first":"2004-08-04","last":"2018-12-27","span_basis":"filed_date"},"name_variants":[{"name":"CATLIN AVERY W","source":"filing","n_filings":15,"first_seen":"2004-08-04","last_seen":"2018-12-27"}],"transactions":[{"id":6306856,"accession":"0001493152-18-018016","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001493152-18-018016","line_url":"/filing/0001493152-18-018016#line-2","is_derivative":false,"issuer_cik":"0001255348","issuer_name":"Provention Bio, Inc.","issuer_ticker":"PRVB","issuer_name_source":null,"issuer_url":"/issuer/0001255348","owner_cik":"0001255348","owner_name":"CATLIN AVERY W","owner_display_name":"CATLIN AVERY W","owner_url":"/insider/0001255348","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":1.85,"price_display":"1.85","price_state":"stated","total_value":9250.0,"total_display":"9,250.00","total_whole":"9,250","shares_owned_after":20000.0,"shares_owned_after_display":"20,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-12-26","filed_date":"2018-12-27","scope":"insider"},{"id":6306852,"accession":"0001493152-18-018016","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-18-018016","line_url":"/filing/0001493152-18-018016#line-1","is_derivative":false,"issuer_cik":"0001255348","issuer_name":"Provention Bio, Inc.","issuer_ticker":"PRVB","issuer_name_source":null,"issuer_url":"/issuer/0001255348","owner_cik":"0001255348","owner_name":"CATLIN AVERY W","owner_display_name":"CATLIN AVERY W","owner_url":"/insider/0001255348","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":1.9,"price_display":"1.90","price_state":"stated","total_value":9500.0,"total_display":"9,500.00","total_whole":"9,500","shares_owned_after":15000.0,"shares_owned_after_display":"15,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-12-24","filed_date":"2018-12-27","scope":"insider"},{"id":6028668,"accession":"0001493152-18-015651","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-18-015651","line_url":"/filing/0001493152-18-015651#line-1","is_derivative":false,"issuer_cik":"0001255348","issuer_name":"Provention Bio, Inc.","issuer_ticker":"PRVB","issuer_name_source":null,"issuer_url":"/issuer/0001255348","owner_cik":"0001255348","owner_name":"CATLIN AVERY W","owner_display_name":"CATLIN AVERY W","owner_url":"/insider/0001255348","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":3.15,"price_display":"3.15","price_state":"stated","total_value":31500.0,"total_display":"31,500.00","total_whole":"31,500","shares_owned_after":10000.0,"shares_owned_after_display":"10,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-11-09","filed_date":"2018-11-13","scope":"insider"},{"id":4540813,"accession":"0001209191-17-031737","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-031737","line_url":"/filing/0001209191-17-031737#line-1","is_derivative":false,"issuer_cik":"0001255348","issuer_name":"Corbus Pharmaceuticals Holdings, Inc.","issuer_ticker":"CRBP","issuer_name_source":null,"issuer_url":"/issuer/0001255348","owner_cik":"0001255348","owner_name":"CATLIN AVERY W","owner_display_name":"CATLIN AVERY W","owner_url":"/insider/0001255348","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":6.1481,"price_display":"6.15","price_state":"stated","total_value":30740.5,"total_display":"30,740.50","total_whole":"30,741","shares_owned_after":47000.0,"shares_owned_after_display":"47,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-05-11","filed_date":"2017-05-12","scope":"insider"},{"id":2704038,"accession":"0001209191-16-151670","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-151670","line_url":"/filing/0001209191-16-151670#line-1","is_derivative":false,"issuer_cik":"0001255348","issuer_name":"Corbus Pharmaceuticals Holdings, Inc.","issuer_ticker":"CRBP","issuer_name_source":null,"issuer_url":"/issuer/0001255348","owner_cik":"0001255348","owner_name":"CATLIN AVERY W","owner_display_name":"CATLIN AVERY W","owner_url":"/insider/0001255348","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":7.55,"price_display":"7.55","price_state":"stated","total_value":15100.0,"total_display":"15,100.00","total_whole":"15,100","shares_owned_after":42000.0,"shares_owned_after_display":"42,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-11-22","filed_date":"2016-11-22","scope":"insider"},{"id":8170860,"accession":"0000905718-15-000933","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000905718-15-000933","line_url":"/filing/0000905718-15-000933#line-2","is_derivative":false,"issuer_cik":"0000744218","issuer_name":"Celldex Therapeutics, Inc.","issuer_ticker":"CLDX","issuer_name_source":null,"issuer_url":"/issuer/0000744218","owner_cik":"0001255348","owner_name":"CATLIN AVERY W","owner_display_name":"CATLIN AVERY W","owner_url":"/insider/0001255348","role":"Officer (Sr. VP & CFO)","role_mark":"O","role_mark_label":"Officer (Sr. VP & CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP & CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":18.0,"price_display":"18.00","price_state":"stated","total_value":450000.0,"total_display":"450,000.00","total_whole":"450,000","shares_owned_after":35109.0,"shares_owned_after_display":"35,109","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-11-23","filed_date":"2015-11-25","scope":"insider"},{"id":8867103,"accession":"0001209191-15-066750","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-066750","line_url":"/filing/0001209191-15-066750#line-1","is_derivative":false,"issuer_cik":"0001255348","issuer_name":"Corbus Pharmaceuticals Holdings, Inc.","issuer_ticker":"CRBP","issuer_name_source":null,"issuer_url":"/issuer/0001255348","owner_cik":"0001255348","owner_name":"CATLIN AVERY W","owner_display_name":"CATLIN AVERY W","owner_url":"/insider/0001255348","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":8212.0,"shares_display":"8,212","price_per_share":1.9,"price_display":"1.90","price_state":"stated","total_value":15602.8,"total_display":"15,602.80","total_whole":"15,603","shares_owned_after":40000.0,"shares_owned_after_display":"40,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-08-18","filed_date":"2015-08-19","scope":"insider"},{"id":8812672,"accession":"0001209191-15-066447","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-15-066447","line_url":"/filing/0001209191-15-066447","is_derivative":false,"issuer_cik":"0001255348","issuer_name":"Corbus Pharmaceuticals Holdings, Inc.","issuer_ticker":"CRBP","issuer_name_source":null,"issuer_url":"/issuer/0001255348","owner_cik":"0001255348","owner_name":"CATLIN AVERY W","owner_display_name":"CATLIN AVERY W","owner_url":"/insider/0001255348","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":11788.0,"shares_display":"11,788","price_per_share":1.9377502544960978,"price_display":"1.94","price_state":"stated","total_value":22842.2,"total_display":"22,842.20","total_whole":"22,842","shares_owned_after":30000.0,"shares_owned_after_display":"30,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-08-17","filed_date":"2015-08-18","scope":"insider","n_lines":3},{"id":8801164,"accession":"0001179110-15-009895","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-15-009895","line_url":"/filing/0001179110-15-009895#line-2","is_derivative":false,"issuer_cik":"0000744218","issuer_name":"Celldex Therapeutics, Inc.","issuer_ticker":"CLDX","issuer_name_source":null,"issuer_url":"/issuer/0000744218","owner_cik":"0001255348","owner_name":"CATLIN AVERY W","owner_display_name":"CATLIN AVERY W","owner_url":"/insider/0001255348","role":"Officer (Sr. VP & CFO)","role_mark":"O","role_mark_label":"Officer (Sr. VP & CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP & CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":24.5901,"price_display":"24.59","price_state":"stated","total_value":614752.5,"total_display":"614,752.50","total_whole":"614,753","shares_owned_after":24609.0,"shares_owned_after_display":"24,609","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-06-15","filed_date":"2015-06-16","scope":"insider"},{"id":8577548,"accession":"0001209191-15-051424","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-051424","line_url":"/filing/0001209191-15-051424#line-1","is_derivative":false,"issuer_cik":"0001255348","issuer_name":"Corbus Pharmaceuticals Holdings, Inc.","issuer_ticker":"CRBP","issuer_name_source":null,"issuer_url":"/issuer/0001255348","owner_cik":"0001255348","owner_name":"CATLIN AVERY W","owner_display_name":"CATLIN AVERY W","owner_url":"/insider/0001255348","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":3.1,"price_display":"3.10","price_state":"stated","total_value":62000.0,"total_display":"62,000.00","total_whole":"62,000","shares_owned_after":20000.0,"shares_owned_after_display":"20,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-06-09","filed_date":"2015-06-09","scope":"insider"},{"id":5465697,"accession":"0001179110-13-017667","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-13-017667","line_url":"/filing/0001179110-13-017667#line-2","is_derivative":false,"issuer_cik":"0000744218","issuer_name":"Celldex Therapeutics, Inc.","issuer_ticker":"CLDX","issuer_name_source":null,"issuer_url":"/issuer/0000744218","owner_cik":"0001255348","owner_name":"CATLIN AVERY W","owner_display_name":"CATLIN AVERY W","owner_url":"/insider/0001255348","role":"Officer (Sr. VP & CFO)","role_mark":"O","role_mark_label":"Officer (Sr. VP & CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP & CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":183333.0,"shares_display":"183,333","price_per_share":24.5,"price_display":"24.50","price_state":"stated","total_value":4491658.5,"total_display":"4,491,658.50","total_whole":"4,491,659","shares_owned_after":14109.0,"shares_owned_after_display":"14,109","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-12-06","filed_date":"2013-12-10","scope":"insider"},{"id":9001713,"accession":"0001179110-11-011961","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-11-011961","line_url":"/filing/0001179110-11-011961#line-1","is_derivative":false,"issuer_cik":"0000744218","issuer_name":"Celldex Therapeutics, Inc.","issuer_ticker":"CLDX","issuer_name_source":null,"issuer_url":"/issuer/0000744218","owner_cik":"0001255348","owner_name":"CATLIN AVERY W","owner_display_name":"CATLIN AVERY W","owner_url":"/insider/0001255348","role":"Officer (Sr. VP & CFO)","role_mark":"O","role_mark_label":"Officer (Sr. VP & CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP & CFO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":2.39,"price_display":"2.39","price_state":"stated","total_value":4780.0,"total_display":"4,780.00","total_whole":"4,780","shares_owned_after":2000.0,"shares_owned_after_display":"2,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-08-09","filed_date":"2011-08-10","scope":"insider"},{"id":7562371,"accession":"0001179110-10-013609","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-10-013609","line_url":"/filing/0001179110-10-013609#line-1","is_derivative":false,"issuer_cik":"0000744218","issuer_name":"Celldex Therapeutics, Inc.","issuer_ticker":"CLDX","issuer_name_source":null,"issuer_url":"/issuer/0000744218","owner_cik":"0001255348","owner_name":"CATLIN AVERY W","owner_display_name":"CATLIN AVERY W","owner_url":"/insider/0001255348","role":"Officer (Sr. VP & CFO)","role_mark":"O","role_mark_label":"Officer (Sr. VP & CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP & CFO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":3.508,"price_display":"3.51","price_state":"stated","total_value":7016.0,"total_display":"7,016.00","total_whole":"7,016","shares_owned_after":2000.0,"shares_owned_after_display":"2,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-09-08","filed_date":"2010-09-09","scope":"insider"},{"id":5819630,"accession":"0001179110-09-016044","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-09-016044","line_url":"/filing/0001179110-09-016044#line-1","is_derivative":false,"issuer_cik":"0000744218","issuer_name":"Celldex Therapeutics, Inc.","issuer_ticker":"CLDX","issuer_name_source":null,"issuer_url":"/issuer/0000744218","owner_cik":"0001255348","owner_name":"CATLIN AVERY W","owner_display_name":"CATLIN AVERY W","owner_url":"/insider/0001255348","role":"Officer (Sr. VP & CFO)","role_mark":"O","role_mark_label":"Officer (Sr. VP & CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP & CFO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":4.408,"price_display":"4.41","price_state":"stated","total_value":4408.0,"total_display":"4,408.00","total_whole":"4,408","shares_owned_after":1000.0,"shares_owned_after_display":"1,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-11-30","filed_date":"2009-12-01","scope":"insider"},{"id":3472240,"accession":"0001179110-06-016872","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-06-016872","line_url":"/filing/0001179110-06-016872#line-1","is_derivative":false,"issuer_cik":"0000744218","issuer_name":"AVANT IMMUNOTHERAPEUTICS INC","issuer_ticker":"AVAN","issuer_name_source":null,"issuer_url":"/issuer/0000744218","owner_cik":"0001255348","owner_name":"CATLIN AVERY W","owner_display_name":"CATLIN AVERY W","owner_url":"/insider/0001255348","role":"Officer (Sr. VP & CFO)","role_mark":"O","role_mark_label":"Officer (Sr. VP & CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP & CFO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":1.35,"price_display":"1.35","price_state":"stated","total_value":6750.0,"total_display":"6,750.00","total_whole":"6,750","shares_owned_after":21000.0,"shares_owned_after_display":"21,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2006-08-16","filed_date":"2006-08-16","scope":"insider"},{"id":527423,"accession":"0001179110-04-015832","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-04-015832","line_url":"/filing/0001179110-04-015832#line-1","is_derivative":false,"issuer_cik":"0000744218","issuer_name":"AVANT IMMUNOTHERAPEUTICS INC","issuer_ticker":"AVAN","issuer_name_source":null,"issuer_url":"/issuer/0000744218","owner_cik":"0001255348","owner_name":"CATLIN AVERY W","owner_display_name":"CATLIN AVERY W","owner_url":"/insider/0001255348","role":"Officer (Sr. VP & CFO)","role_mark":"O","role_mark_label":"Officer (Sr. VP & CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP & CFO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3500.0,"shares_display":"3,500","price_per_share":1.825,"price_display":"1.82","price_state":"stated","total_value":6387.5,"total_display":"6,387.50","total_whole":"6,388","shares_owned_after":10000.0,"shares_owned_after_display":"10,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2004-08-03","filed_date":"2004-08-04","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":18,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":15,"open_market":true},{"code":"S","label":"Open-market sale","n":3,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":18},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001695357","name":"Provention Bio, Inc.","url":"/issuer/0001695357","role":"Director","n_filings":2,"first_seen":"2018-11-13","last_seen":"2018-12-27"},{"type":"issuer","type_label":"ISSUER","cik":"0001595097","name":"Corbus Pharmaceuticals Holdings, Inc.","url":"/issuer/0001595097","role":"Director","n_filings":5,"first_seen":"2015-06-09","last_seen":"2017-05-12"},{"type":"issuer","type_label":"ISSUER","cik":"0000744218","name":"Celldex Therapeutics, Inc.","url":"/issuer/0000744218","role":"Officer (Sr. VP & CFO)","n_filings":8,"first_seen":"2004-08-04","last_seen":"2015-11-25"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001255348","retrieved_at":"2026-08-23T22:50:56+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}